Latest filing published 16 Jun 2026 for MediPharm Labs Corp..
No signal scores available.
Emily Jameson appears in our data through filings on MediPharm Labs Corp. shares, published by SEDI. In total, 5 filings cover trades dated from 16 June 2025 to 9 June 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
Most recently, on 16 June 2026, the filings show an option exercise in MediPharm Labs Corp. Filings reach the SEDI feed a median of 7 days after the trade. Until a filing is published, the market cannot know about the trade. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations